Safety, tolerability, pharmacokinetics and target engagement of GSK3858279 in healthy Caucasian, Chinese and Japanese participants

Trial Identifier: 212979
Sponsor: GlaxoSmithKline
Collaborator:
NA
Start Date: February 2022
Primary Completion Date: February 2023
Study Completion Date: April 2023
Condition: Other

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

Language Description

Trial Locations

Country Location
Australia, QLD Herston Queensland, QLD, Australia, 4006
Australia, VIC Melbourne, VIC, Australia, 3004